About Hummsa Biotech
Hummsa Biotech is a Healthcare company based in Kolkata (India) founded in 2022 by Swapnil Sinha and Harshad Lalwani. Nanotechnology-based diagnostic devices for various diseases are developed. Hummsa Biotech has raised $166.27 thousand across 2 funding rounds from investors including IIIT Hyderabad, 100X.VC and Yagnesh Sanghrajka. The company has 1 employees. Hummsa Biotech was last valued at $1.01 million in February 2024. Its chief executive, as recorded, is Harshad Lalwani. Hummsa Biotech offers products and services including InsGen Kit and Novel Platform Reagent Technology. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity in India is Hummsa Biotech Private Limited (U24239WB2022PTC253326).
Company details
Hummsa Biotech was founded in 2022 in Kolkata, India, within the biotechnology sector. A nanotechnology-based device for disease diagnostics is developed by the company, with operations centered on integrating synthetic biology and AI. The product, InsGen, enables simultaneous proprietary assays to address diagnostics for multiple diseases, supporting advancements in healthcare applications across the region.
- Headquarters Kolkata, India
- Employees 1
- Founders Swapnil Sinha, Harshad Lalwani
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website hummsabiotech.com
- Social LinkedIn
- Legal Name Hummsa Biotech Private Limited
- Date of Incorporation 26 Apr, 2022
- Jurisdiction Kolkata, West Bengal, India
- Annual Revenue₹20,000
FY 2024 · -33% YoY
- Net Loss-₹14.5 Lakh
FY 2024 · -7245% margin
- EBITDA-₹14.2 Lakh
FY 2024 · -7118% margin
- Total Equity Funding$166.27K (USD)
in 2 rounds
- Latest Funding Round$166.27K (USD), Seed
Feb 2024
- InvestorsIIIT Hyderabad
& 4 more
- Employee Count1
Associated legal entities of Hummsa Biotech
Hummsa Biotech operates through Hummsa Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hummsa Biotech Private Limited CIN U24239WB2022PTC253326 | Active | 26 Apr 2022 | Kolkata, West Bengal | ₹0.0 Cr | 2 | View details |
Products & Services of Hummsa Biotech
Hummsa Biotech offers a comprehensive portfolio of products and services, including InsGen Kit and Novel Platform Reagent Technology.
Rapid DNA/RNA sensor for accurate target detection and quantitative results.
Technology for quick, precise detection of critical health targets.
Funding Insights of Hummsa Biotech
Hummsa Biotech has successfully raised a total of $166.27K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $166.27 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $166,273
- Total Rounds 2
- Last Round Seed — $166,273
- Investors Count 5
All 2 funding rounds of Hummsa Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $166,273 | Seed | $1.01M | 100X.VC | |
| Mar 2023 | Seed | – | IIIT Hyderabad |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2024 | $1.01M | •••••••• |
Last known valuation $1.01M (Feb 2024). 5 investors in total: 3 institutional and 2 angel.
Investors in Hummsa Biotech
Hummsa Biotech has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include IIIT Hyderabad, 100X.VC and Yagnesh Sanghrajka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are funded by 100X.VC venture capital firm. | 100x.vc | Mumbai, India | ||
Healthcare startups are accelerated by a dedicated incubator program. | cie.iiit.ac.in/medtech-incubator | Hyderabad, India | ||
Information technology courses are offered at undergraduate and postgraduate levels. | 1998 | iiit.ac.in | Hyderabad, India | |
YS Yagnesh Sanghrajka | CFO of 100X.VC, angel investor, and startup mentor in India | unknown_7a304f7575c147e88 | ||
SR Shashank Randev | Founder of 100X.VC, active angel investor in Indian startups | unknown_39465f8ddde646279 |
Investor details for Hummsa Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Hummsa Biotech Private Limited (Hummsa Biotech)
Hummsa Biotech Private Limited is the primary company behind Hummsa Biotech. The board of Hummsa Biotech Private Limited currently have 2 directors; the longest-serving is Harshad Lalwani, appointed in 2022. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harshad Lalwani DIN 07116907 | Director | 26 Apr 2022 | 4 yrs 6 mo | Hummsa Biotech Private Limited |
| Mayukh Bose DIN 09004824 | Director | 22 Aug 2024 | 2 yrs 2 mo | Hummsa Biotech Private Limited |
People of Hummsa Biotech
2 people are tracked at Hummsa Biotech (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Swapnil Sinha | Co-Founder | Leadership |
| Co-Founder & CEO | Leadership |
Complete people profiles for Hummsa Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Hummsa Biotech
Figures of Hummsa Biotech Private Limited, the primary company behind Hummsa Biotech, for FY 2024. Revenue was ₹20,000 (-33% year on year). Net loss was -₹14.5 Lakh (-7245% margin). EBITDA was -₹14.2 Lakh (-7118% margin).
- ₹20,000Revenue · FY 2024 · -33% YoY
- -₹14.5 LakhNet loss · -7245% margin
- -₹14.2 LakhEBITDA · -7118% margin
- ₹1.4 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Hummsa Biotech Private Limited are on its company page.
Detailed financial statements for Hummsa Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Hummsa Biotech
4 dated milestones of Hummsa Biotech across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Hummsa Biotech is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $166K.
- Milestone Reaches Minicorn status.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hummsa Biotech
Hummsa Biotech was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Hummsa Biotech is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
Harshad Lalwani is the CEO of Hummsa Biotech, as recorded in our data. They have also founded this company.
Hummsa Biotech is a funded company, having raised a total of $166.27K across 2 funding rounds to date.
Hummsa Biotech has 1 employees.
The primary company behind Hummsa Biotech, Hummsa Biotech Private Limited, reported revenue of ₹20,000 for FY 2024, down 33% year on year.
Hummsa Biotech was founded in 2022 in Kolkata, India, within the biotechnology sector. A nanotechnology-based device for disease diagnostics is developed by the company, with operations centered on integrating synthetic biology and AI. The product, InsGen, enables simultaneous proprietary assays to address diagnostics for multiple diseases, supporting advancements in healthcare applications across the region.
Hummsa Biotech offers InsGen Kit and Novel Platform Reagent Technology.
Hummsa Biotech has 5 investors. Key investors include IIIT Hyderabad, 100X.VC, Yagnesh Sanghrajka, Shashank Randev, and CIE MedTech Incubator.
The valuation of Hummsa Biotech is $1.01M as of Feb 2024.
Hummsa Biotech operates through Hummsa Biotech Private Limited.
The legal entities of Hummsa Biotech currently have 2 directors, including Harshad Lalwani, Mayukh Bose.